LSP Dementia Fund
VC Fund
LSP Dementia Fund is a venture capital fund managed by Life Sciences Partners.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries LSP Dementia Fund invests in
Stages LSP Dementia Fund invests in
Countries LSP Dementia Fund invests in
Round sizes
Round size
- Series A
- $39M–$39M
Investment Focus
Industry
- Biotechnology 3 (60%)
- Health Care 1 (20%)
- Life Science 1 (20%)
- Therapeutics 1 (20%)
- Pharmaceutical 1 (20%)
Stage
- Series A 1 (20%)
- Series B 1 (20%)
- Post-IPO Equity 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- Belgium 1 (20%)
- Ireland 1 (20%)
- United States 1 (20%)
- The Netherlands 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aerska
|
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain disorders. | $39M / Series A / Feb 09, 2026 | |
|
Aerska
|
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain disorders. | $39M / Series A / Feb 09, 2026 | |
QurAlis
|
QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS . | $88M / Series B / Mar 09, 2023 | |
New Amsterdam Pharma
|
NewAmsterdam Pharma is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases. | $235M / Post-IPO Equity / Nov 23, 2022 | |
Nobi
|
Nobi is a smart lamp that ensures help can be provided in a flash in the event of a fall. It recognizes a fall, and it will notify a family member, contacts, or a specialized emergency call center. The lamp will then connect to that person to reassure them that help is on the way. If necessary, it can even unlock the smart lock on the front door. | $14.5M / Venture - Series Unknown / Jan 28, 2022 |
Co-Investors
age1
2 deals together
Iaso Ventures
2 deals together
EQT Life Sciences
2 deals together
Bain Capital Life Sciences
1 deal together
Mission BioCapital
1 deal together
BNP Paribas Fortis
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does LSP Dementia Fund invest in?
LSP Dementia Fund invests primarily in Biotechnology, Health Care and Life Science startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is LSP Dementia Fund's check size?
LSP Dementia Fund typically joins rounds of $39M–$39M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds LSP Dementia Fund participates in.
When did LSP Dementia Fund last invest?
The most recent investment recorded for LSP Dementia Fund closed in Feb 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
